Samuel W Brady Selected Research

Samuel W Brady Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 04/2011
10	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2011
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2020
4	Leukemia 01/2023 - 01/2021
2	Neuroblastoma 11/2021 - 10/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Brain Neoplasms (Brain Tumor) 11/2021
1	Cardiotoxicity 11/2021
1	Turcot syndrome 01/2021
1	Residual Neoplasm 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hyperplasia 11/2017
1	Lung Neoplasms (Lung Cancer) 03/2015
1	Carcinoma (Carcinomatosis) 03/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2014
4	RNA (Ribonucleic Acid)IBA 12/2021 - 11/2021
4	Trastuzumab (Herceptin)FDA Link 05/2014 - 04/2011
3	2-mercaptopurineIBA 01/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2021
3	Estrogen ReceptorsIBA 01/2021 - 11/2015
3	Lapatinib (GW572016)FDA Link 01/2015 - 01/2014
2	Aromatase InhibitorsIBA 11/2017 - 11/2015
1	GlucocorticoidsIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	crenolanibIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 11/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	CX 5461IBA 11/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Monomeric GTP-Binding ProteinsIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2017
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2017
1	saracatinibIBA 11/2015
1	Tamoxifen FDA LinkGeneric 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	src-Family KinasesIBA 11/2015
1	Tyrosine Kinase InhibitorsIBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 05/2014
1	dactolisibIBA 05/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014
1	Mitogen-Activated Protein KinasesIBA 09/2012
1	triciribineIBA 09/2012

Therapy/Procedure

16	Therapeutics 01/2023 - 04/2011
4	Drug Therapy (Chemotherapy) 01/2021 - 11/2017
1	Aftercare (After-Treatment) 11/2021
1	Immunotherapy 11/2021
1	Incubators 10/2021